Denali Therapeutics (DNLI) EBT Margin Growth (1y) (2019 - 2023)
Denali Therapeutics (DNLI) EBT Margin Growth (1y) (2019 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 452.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,076.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9,422.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -392.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1,911.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,565.00 |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -478,088.00 |
| Jun 30, 2023 | 17,433.00 |
| Mar 31, 2023 | -15,692.00 |
| Dec 31, 2022 | -83,097.00 |
| Sep 30, 2022 | -146,018.00 |
| Jun 30, 2022 | 29,263.00 |
| Mar 31, 2022 | 72,012.00 |
| Dec 31, 2021 | -23,343.00 |
| Sep 30, 2021 | -98,089.00 |
| Jun 30, 2021 | 60,519.00 |
| Mar 31, 2021 | 10.85 Mn |
| Dec 31, 2020 | 372,634.00 |
| Sep 30, 2020 | 44,650.00 |
| Jun 30, 2020 | 42,139.00 |
| Mar 31, 2020 | -10.85 Mn |
| Dec 31, 2019 | -371,047.00 |
| Sep 30, 2019 | 189,377.00 |
| Jun 30, 2019 | 188,945.00 |
| Mar 31, 2019 | 1.80 Mn |